Peptide-dependent vectors have gained consideration for their specificity in binding to receptors overexpressed in breast cancer cells, probably overcoming problems associated with minimal internalization. Clinical trials and preclinical studies are highlighted, demonstrating the efficacy of peptide vaccines in inducing an immune response, with the probable to improve survival charges... https://johne999lbn1.buyoutblog.com/profile